0001493152-24-033549.txt : 20240822
0001493152-24-033549.hdr.sgml : 20240822
20240822155715
ACCESSION NUMBER: 0001493152-24-033549
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240725
FILED AS OF DATE: 20240822
DATE AS OF CHANGE: 20240822
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Perego Kenneth II
CENTRAL INDEX KEY: 0001840012
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-56151
FILM NUMBER: 241231901
MAIL ADDRESS:
STREET 1: 4704 COLLINGSBURG DR.
CITY: ALEXANDRIA
STATE: LA
ZIP: 71303
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: One World Products, Inc.
CENTRAL INDEX KEY: 0001622244
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 611744826
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6605 GRAND MONTECITO PKWY
STREET 2: SUITE 100
CITY: LAS VEGAS
STATE: NV
ZIP: 89149
BUSINESS PHONE: 7026050605
MAIL ADDRESS:
STREET 1: 6605 GRAND MONTECITO PKWY
STREET 2: SUITE 100
CITY: LAS VEGAS
STATE: NV
ZIP: 89149
FORMER COMPANY:
FORMER CONFORMED NAME: One World Pharma, Inc.
DATE OF NAME CHANGE: 20190125
FORMER COMPANY:
FORMER CONFORMED NAME: PUNTO GROUP, CORP.
DATE OF NAME CHANGE: 20141014
4
1
ownership.xml
X0508
4
2024-07-25
0
0001622244
One World Products, Inc.
OWPC
0001840012
Perego Kenneth II
6605 GRAND MONTECITO PKWY., SUITE 100
LAS VEGAS
NV
89149
1
0
0
0
0
Common Stock
7000000
I
See footnote
Common Stock
5785000
D
Series A Preferred Stock
2024-07-25
4
A
0
15000
150000
A
2024-07-25
Common Stock
1500000
2600000
I
See footnote
Warrants to Purchase Common Stock
0.25
2024-07-25
4
A
0
1500000
0.00
A
2024-07-25
2029-07-25
Common Stock
1500000
2050000
I
See footnote
15,000 shares of Series A Preferred Stock and a Warrant to Purchase Common Stock of the Issuer were purchased, in units, by the Reporting Person for $150,000 in cash. Each share of Series A Preferred Stock is convertible at any time, at the Reporting Person's election, into 100 shares of the Issuer's common stock and has no expiration date
Each share of Series A Preferred Stock is convertible at any time, at the election of the Reporting Person, into 100 shares of common stock of the Issuer.
The Warrant to Purchase Common Stock is exercisable at any time, at the election of the Reporting Person, at an exercise price of $0.25 per share.
Owned of record by Perego Trust, of which the Reporting Person is Trustee.
Owned of record by CB Medical, LLC, of which the Reporting Person is the owner.
All of the purchase price was allocated to the shares of Series A Preferred Stock.
The Reporting Person beneficially owns a total of 17,785,000 shares of common stock of the Issuer.
This is a late Form 4 filing.
/s/ Dr. Kenneth Perego, II, M.D.
2024-08-22